Diagnostic Axillary US: How Indication and Breast Cancer Status Impact Diagnostic Outcomes
Journal of Breast Imaging · 2026
DOI: 10.1093/jbi/wbaf040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Breast Imaging, 2026. Verfasst von Howard Z Yan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Stanford University Medical Center, Stanford, CA, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphatic Metastasis. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objective
To determine how indication and breast cancer status impact the observed prevalence of lymph node (LN) metastases, axillary US (AxUS) performance indices, and sonographic presentation of metastatic LNs.
Methods
In total, 2156 consecutive AxUS examinations in 1719 women >18 years old from May 22, 2017, to December 10, 2020, were identified. Indication, breast cancer status, and imaging results were obtained. Lymph node status was established ≥1 year follow-up. Axillary US examinations were reviewed, blinded to clinical and pathology outcomes. Axillary US performance indices were compared by cancer status using an unpaired proportion test. Lymph node characteristics between breast cancer statuses were assessed using logistic regression analysis.
Results
Observed LN metastases prevalence in the overall study population was 1.7% (23/1340). In all, 62.2% (1340/2156) of AxUS examinations were performed in women without breast cancer; “Treatment planning” made up only 5% (108/2156) and had the highest prevalence—24.1% (26/108). Lymph node metastases prevalence was between 0% and 0.7% for all indications in women without breast cancer other than AxUS prompted by another imaging modality. “Follow-up” and “routine” axillary evaluation during diagnostic breast US had a combined prevalence of 0.20% (1/504). Metastatic LNs in women without current/suspected breast cancer had larger cortices and were more likely to have an absent hilum and abnormal shape.
Conclusion
This study highlights the need to incorporate examination indication and cancer status during AxUS interpretation, particularly in women without current or suspected breast cancer. It is also important to be cognizant of observed differences in sonographic features of LN metastasis based on breast cancer status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Stanford University Medical Center, Stanford, CA, USA.
ORCID-Profile: Brittany Z Dashevsky, Uzma Waheed, Steven P Poplack
Zitieren
APA
Yan, H. Z., Liang, T., DeMartini, W. B., Pittman, S. M., Dashevsky, B. Z., Rosen, E. L., Ikeda, D. M., Waheed, U., Lipson, J. A., & Poplack, S. P. (2026). Diagnostic Axillary US: How Indication and Breast Cancer Status Impact Diagnostic Outcomes. Journal of Breast Imaging. https://doi.org/10.1093/jbi/wbaf040
Vancouver
Yan HZ, Liang T, DeMartini WB, Pittman SM, Dashevsky BZ, Rosen EL, et al. Diagnostic Axillary US: How Indication and Breast Cancer Status Impact Diagnostic Outcomes. Journal of Breast Imaging. 2026. doi:10.1093/jbi/wbaf040
BibTeX
@article{Yan2026,
author = {Yan, Howard Z and Liang, Tie and DeMartini, Wendy B and Pittman, Sarah M and Dashevsky, Brittany Z and Rosen, Eric L and Ikeda, Debra M and Waheed, Uzma and Lipson, Jafi A and Poplack, Steven P},
title = {Diagnostic Axillary US: How Indication and Breast Cancer Status Impact Diagnostic Outcomes},
journal = {Journal of Breast Imaging},
year = {2026},
doi = {10.1093/jbi/wbaf040}
}
EUVIMED